One of the most common birth defects worldwide is hearing loss. Every 1,000 babies born worldwide are affected by permanent hearing loss in one or both ears. Hearing loss can significantly affect a baby's development.
CapitalBiotech has developed the Hereditary Deafness Gene Detection Assay using semiconductor sequencing technology. It can identify 100 mutant sites on 18 deafness-related genes such as GJB2, SLA26A4, GJB3, MT-RNR1, and others. This detection assay boasts an accuracy of over 99.9%.
The BioElectron Gene Squencer 4000 platform was developed in collaboration with Thermo Fisher. It can detect 384 samples simultaneously.
Introduction to Microarray Chip Analysis TechnologyApril 10, 2024Microarray chip analysis technology, as an important innovation in the field of modern biotechnology, plays an increasingly important role in the fields of genomics, proteomics, and disease diagnosis ...view
Small Container with Big Wisdom: Taking You Inside Cabin LabsApril 16, 2025Introduction to the Cabin LabsThe cabin labs are modular, mobile temporary laboratory facilities often used in emergency, disaster relief, disease control, and other situations. They utilize prefabric...view
Applications of Microarray Platforms in Modern Biological ResearchApril 2, 2026Microarray platforms are essential tools in genomics and molecular biology, providing an efficient and high-throughput method for simultaneously measuring the expression of thousands of genes or detec...view
Application Prospects of in Vitro Diagnostic TechnologyMarch 9, 2023The development of in vitro diagnostic (IVD) technologies has been rapid, spanning from genetic sequencing, SNP screening, point mutation gene diagnosis at the gene level, to the detection of various ...view
Clinical Applications of Genetic SequencersApril 4, 2023Genetic sequencer, also known as DNA sequencer, is an instrument used to determine the sequence, type, and quantity of nucleotides in a DNA fragment. It is mainly used in human genome sequencing, gene...view